Mylan (MYL), Endo (ENDP) Gain on Valeant Headlines

November 1, 2016 3:48 PM EDT

Find out which companies are about to raise their dividend well before the news hits the Street with's Dividend Insider Elite. Sign-up for a FREE trial here.

Endo Int'l (NASDAQ: ENDP), Mylan (NASDAQ: MYL) gain on reports Valeant Pharma (NYSE: VRX) is in advanced talks to sell Salix to Takeda for $10 billion.

Serious News for Serious Traders! Try Premium Free!

You May Also Be Interested In

Related Categories

Trader Talk

Add Your Comment